Stock KYMR KYMERA THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Kymera Therapeutics, Inc.

Equities

KYMR

US5015751044

Market Closed - Nasdaq
Other stock markets
 10:30:00 03/07/2024 pm IST 		5-day change 1st Jan Change
30.16 USD -0.20% Intraday chart for Kymera Therapeutics, Inc. +0.90% +18.46%
14/06 Kymera Therapeutics Presents New Clinical Data from the Ongoing Phase 1 Trial of Stat3 Degrader Kt-333 At Eha Annual Meeting CI
11/06 Transcript : Kymera Therapeutics, Inc. Presents at Goldman Sachs 45th Annual Global Healthcare Conference, Jun-11-2024 02:40 PM
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Other Biotechnology & Medical Research

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
KYMERA THERAPEUTICS, INC. Stock Kymera Therapeutics, Inc.
 1.85B -
MODERNA, INC. Stock Moderna, Inc.
 44.44B -
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
 37.68B
LONZA GROUP AG Stock Lonza Group AG
 39.84B
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
 31.46B -
CELLTRION, INC. Stock Celltrion, Inc.
 27.02B
  1. Stock Market
  2. Equities
  3. KYMR Stock
  4. Charts Kymera Therapeutics, Inc.
  5. Sector Chart